FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

385108009: Conventional release cutaneous solution (dose form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1479370017 Cutaneous solution en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3558864015 Conventional release cutaneous solution (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3558865019 Conventional release cutaneous solution en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
176701000052117 kutan lösning sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cutaneous solution Is a kutan och/eller transdermal läkemedelsform false Inferred relationship Some
Cutaneous solution Is a läkemedelslösning false Inferred relationship Some
Cutaneous solution Is a Cutaneous dose form true Inferred relationship Some
Cutaneous solution Has dose form administration method (attribute) Apply (administration method) true Inferred relationship Some
Cutaneous solution Has dose form intended site (attribute) Cutaneous (intended site) true Inferred relationship Some
Cutaneous solution Has dose form release characteristic (attribute) Conventional release (release characteristic) true Inferred relationship Some
Cutaneous solution Has basic dose form (attribute) Solution true Inferred relationship Some
Cutaneous solution Has dose form transformation (attribute) No transformation true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
amorolfinhydroklorid 50 milligram/milliliter, kutan lösning Has manufactured dose form False Cutaneous solution Inferred relationship Some
Lactic acid (as ammonium lactate) 167 mg/mL and salicylic acid 167 mg/mL cutaneous solution Has manufactured dose form True Cutaneous solution Inferred relationship Some
Product containing precisely povidone iodine 50 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Cutaneous solution Inferred relationship Some
Minoxidil 50 mg/mL cutaneous solution Has manufactured dose form True Cutaneous solution Inferred relationship Some
Product containing precisely betamethasone (as betamethasone valerate) 1 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Cutaneous solution Inferred relationship Some
Product containing precisely ethanol 0.7 milliliter/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Cutaneous solution Inferred relationship Some
Amorolfine (as amorolfine hydrochloride) 50 mg/mL cutaneous solution Has manufactured dose form True Cutaneous solution Inferred relationship Some
Cetrimide 5 mg/mL and chlorhexidine gluconate 500 microgram/mL cutaneous solution Has manufactured dose form True Cutaneous solution Inferred relationship Some
Minoxidil 100 mg/mL cutaneous solution Has manufactured dose form True Cutaneous solution Inferred relationship Some
Minoxidil 20 mg/mL cutaneous solution Has manufactured dose form True Cutaneous solution Inferred relationship Some
Product containing precisely chloroxylenol 48 milligram/1 milliliter conventional release cutaneous solution (clinical drug) Has manufactured dose form True Cutaneous solution Inferred relationship Some

Start Page 2 of 2


This concept is not in any reference sets

Back to Start